Neural tumor-initiating cells have distinct telomere maintenance and can be safely targeted for telomerase inhibition.
Castelo-Branco P, Zhang C, Lipman T, Fujitani M, Hansford L, Clarke I, Harley CB, Tressler R, Malkin D, Walker E, Kaplan DR, Dirks P, Tabori U.
Castelo-Branco P, et al. Among authors: malkin d.
Clin Cancer Res. 2011 Jan 1;17(1):111-21. doi: 10.1158/1078-0432.CCR-10-2075.
Clin Cancer Res. 2011.
PMID: 21208905
Free article.